Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Unknown × Breast Neoplasms × Ropivacaine × Clear all

Phase

Phase EARLY_PHASE1 1

Status

Completed 11 Withdrawn 1 Unknown 1 Terminated 1 Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Pain, Postoperative 3 Pain 3 Supratentorial Neoplasms 1 Prostatic Neoplasms 1 Postoperative Complications 1 Pancreatic Ductal Adenocarcinoma 1 Pain, Intractable 1 Oropharyngeal Neoplasms 1 Neoplasms 1 Lung Neoplasms 1 Liver Neoplasms 1 Liver Diseases 1 Colorectal Neoplasms 1 Colonic Neoplasms 1 Cancer Pain 1 Breast Neoplasms 1 Benign Gynecologic Neoplasm 1 Agnosia 1 Acute Pain 1

Interventions

Cyclophosphamide 69 Docetaxel 60 Capecitabine 59 Trastuzumab 54 Paclitaxel 45 Tamoxifen 42 Epirubicin 40 Fulvestrant 34 Doxorubicin 34 Letrozole 33 Radiotherapy 32 pyrotinib 31 Vinorelbine 30 Carboplatin 29 exemestane 25 Anastrozole 24 Neoadjuvant Therapy 22 Fluorouracil 19 Drug Therapy 19 palbociclib 18 Chemotherapy, Adjuvant 17 Bevacizumab 17 Exercise 16 liposomal doxorubicin 14 Cisplatin 14 pertuzumab 13 Goserelin 13 Gemcitabine 13 Albumin-Bound Paclitaxel 13 Mammography 12

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02719795 2017-02-17

PNBCP

First Affiliated Hospital Xi'an Jiaotong University

Phase EARLY_PHASE1 Unknown

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡